Is ACTU or ACXP more undervalued in 2026?

CirclFi compares Actuate Therapeutics, Inc. (ACTU) and Acurx Pharmaceuticals, Inc. (ACXP) using 13 institutional-grade valuation models. ACTU has a Quality of Company score of 3.7/10 while ACXP scores 3.8/10.

Which is a better buy — ACTU or ACXP?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ACTU and ACXP valuations compare?

ACTU at $2.08 and ACXP at $1.99 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ACTU vs ACXP Valuation Comparison 2026 — Intrinsic Value Analysis

ACTU

Biotechnology

Actuate Therapeutics, Inc.

Quality

3.7

out of 10

Value Trap

SAFE

Price

$2.08

Last close

Models

7/13

Active

ACXP

Biotechnology

Acurx Pharmaceuticals, Inc.

Quality

3.8

out of 10

Value Trap

SAFE

Price

$1.99

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	ACTU Fair Value	ACTU Upside	ACXP Fair Value	ACXP Upside
Bayesian DCF	Intrinsic	$0.74	-64.6%	$1.71	-14.0%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.04	-98.6%	$0.12	-94.7%
Dynamic NAV	Asset-Based	$0.85	-59.2%	$3.01	+51.4%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ACTU vs ACXP — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ACTU vs ACXP — Which Stock Is More Undervalued?

ACXP scores higher with a 3.8/10 quality rating vs ACTU's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Actuate Therapeutics, Inc. (ACTU) and Acurx Pharmaceuticals, Inc. (ACXP) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ACTU currently trades at $2.08 with a QOC of 3.7/10, while ACXP trades at $1.99 with a QOC of 3.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).